National Vision (EYE) Competitors

$17.72 +0.80 (+4.73%)

Closing price 04:00 PM Eastern

Extended Trading

$17.87 +0.15 (+0.85%)

As of 06:12 PM Eastern

EYE vs. NVST, BLCO, STVN, IRTC, and LQDA

Should you buy National Vision stock or one of its competitors? MarketBeat compares National Vision with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with National Vision include Envista (NVST), Bausch + Lomb (BLCO), Stevanato Group (STVN), iRhythm Technologies (IRTC), and Liquidia (LQDA). These companies are all part of the "medical equipment" industry.

How does National Vision compare to Envista?

National Vision (NASDAQ:EYE) and Envista (NYSE:NVST) are both medical equipment companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, earnings, profitability, media sentiment, dividends, analyst recommendations, risk and institutional ownership.

Envista has higher revenue and earnings than National Vision. National Vision is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
National Vision	$1.99B	0.71	$29.60M	$0.37	47.89
Envista	$2.81B	1.38	$47M	$0.41	58.12

Envista has a net margin of 2.41% compared to National Vision's net margin of 1.49%. Envista's return on equity of 7.11% beat National Vision's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
National Vision	1.49%	5.15%	2.22%
Envista	2.41%	7.11%	3.91%

In the previous week, National Vision had 10 more articles in the media than Envista. MarketBeat recorded 20 mentions for National Vision and 10 mentions for Envista. National Vision's average media sentiment score of 1.07 beat Envista's score of 0.56 indicating that National Vision is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
National Vision	9 Very Positive mention(s)	4 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Envista	4 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

National Vision has a beta of 1.18, indicating that its stock price is 18% more volatile than the broader market. Comparatively, Envista has a beta of 0.92, indicating that its stock price is 8% less volatile than the broader market.

National Vision presently has a consensus price target of $29.31, suggesting a potential upside of 65.39%. Envista has a consensus price target of $28.83, suggesting a potential upside of 21.00%. Given National Vision's stronger consensus rating and higher possible upside, equities analysts plainly believe National Vision is more favorable than Envista.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
National Vision	0 Sell rating(s)	6 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.54
Envista	0 Sell rating(s)	9 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.40

Summary

Envista beats National Vision on 8 of the 14 factors compared between the two stocks.

How does National Vision compare to Bausch + Lomb?

National Vision (NASDAQ:EYE) and Bausch + Lomb (NYSE:BLCO) are both medical equipment companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, profitability, media sentiment, valuation, risk, dividends, analyst recommendations and institutional ownership.

National Vision has higher earnings, but lower revenue than Bausch + Lomb. Bausch + Lomb is trading at a lower price-to-earnings ratio than National Vision, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
National Vision	$1.99B	0.71	$29.60M	$0.37	47.89
Bausch + Lomb	$5.10B	1.14	-$360M	-$0.62	N/A

11.1% of Bausch + Lomb shares are held by institutional investors. 2.4% of National Vision shares are held by company insiders. Comparatively, 1.5% of Bausch + Lomb shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

National Vision has a net margin of 1.49% compared to Bausch + Lomb's net margin of -4.21%. National Vision's return on equity of 5.15% beat Bausch + Lomb's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
National Vision	1.49%	5.15%	2.22%
Bausch + Lomb	-4.21%	3.60%	1.69%

In the previous week, National Vision had 15 more articles in the media than Bausch + Lomb. MarketBeat recorded 20 mentions for National Vision and 5 mentions for Bausch + Lomb. National Vision's average media sentiment score of 1.07 beat Bausch + Lomb's score of 0.16 indicating that National Vision is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
National Vision	9 Very Positive mention(s)	4 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Bausch + Lomb	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

National Vision has a beta of 1.18, suggesting that its share price is 18% more volatile than the broader market. Comparatively, Bausch + Lomb has a beta of 0.59, suggesting that its share price is 41% less volatile than the broader market.

National Vision currently has a consensus price target of $29.31, suggesting a potential upside of 65.39%. Bausch + Lomb has a consensus price target of $18.08, suggesting a potential upside of 11.17%. Given National Vision's stronger consensus rating and higher probable upside, research analysts clearly believe National Vision is more favorable than Bausch + Lomb.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
National Vision	0 Sell rating(s)	6 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.54
Bausch + Lomb	1 Sell rating(s)	9 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.21

Summary

National Vision beats Bausch + Lomb on 13 of the 16 factors compared between the two stocks.

How does National Vision compare to Stevanato Group?

National Vision (NASDAQ:EYE) and Stevanato Group (NYSE:STVN) are both medical equipment companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, profitability, media sentiment, valuation, risk, dividends, analyst recommendations and institutional ownership.

National Vision currently has a consensus price target of $29.31, suggesting a potential upside of 65.39%. Given National Vision's stronger consensus rating and higher probable upside, research analysts clearly believe National Vision is more favorable than Stevanato Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
National Vision	0 Sell rating(s)	6 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.54
Stevanato Group	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Stevanato Group has lower revenue, but higher earnings than National Vision. Stevanato Group is trading at a lower price-to-earnings ratio than National Vision, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
National Vision	$1.99B	0.71	$29.60M	$0.37	47.89
Stevanato Group	€1.34B	4.03	€158.21M	€0.59	30.25

National Vision has a beta of 1.18, indicating that its stock price is 18% more volatile than the broader market. Comparatively, Stevanato Group has a beta of 0.75, indicating that its stock price is 25% less volatile than the broader market.

Stevanato Group has a net margin of 11.76% compared to National Vision's net margin of 1.49%. Stevanato Group's return on equity of 10.27% beat National Vision's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
National Vision	1.49%	5.15%	2.22%
Stevanato Group	11.76%	10.27%	6.08%

In the previous week, National Vision had 14 more articles in the media than Stevanato Group. MarketBeat recorded 20 mentions for National Vision and 6 mentions for Stevanato Group. National Vision's average media sentiment score of 1.07 beat Stevanato Group's score of 0.15 indicating that National Vision is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
National Vision	9 Very Positive mention(s)	4 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Stevanato Group	0 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

National Vision beats Stevanato Group on 8 of the 14 factors compared between the two stocks.

How does National Vision compare to iRhythm Technologies?

iRhythm Technologies (NASDAQ:IRTC) and National Vision (NASDAQ:EYE) are both medical equipment companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, profitability, earnings, media sentiment, risk, analyst recommendations, institutional ownership and dividends.

iRhythm Technologies currently has a consensus price target of $193.38, suggesting a potential upside of 69.40%. National Vision has a consensus price target of $29.31, suggesting a potential upside of 65.39%. Given iRhythm Technologies' stronger consensus rating and higher possible upside, equities analysts clearly believe iRhythm Technologies is more favorable than National Vision.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
iRhythm Technologies	1 Sell rating(s)	1 Hold rating(s)	11 Buy rating(s)	2 Strong Buy rating(s)	2.93
National Vision	0 Sell rating(s)	6 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.54

National Vision has higher revenue and earnings than iRhythm Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than National Vision, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
iRhythm Technologies	$787.85M	4.76	-$44.55M	-$0.86	N/A
National Vision	$1.99B	0.71	$29.60M	$0.37	47.89

iRhythm Technologies has a beta of 1.33, meaning that its stock price is 33% more volatile than the broader market. Comparatively, National Vision has a beta of 1.18, meaning that its stock price is 18% more volatile than the broader market.

National Vision has a net margin of 1.49% compared to iRhythm Technologies' net margin of -3.53%. National Vision's return on equity of 5.15% beat iRhythm Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
iRhythm Technologies	-3.53%	-10.26%	-1.39%
National Vision	1.49%	5.15%	2.22%

In the previous week, National Vision had 15 more articles in the media than iRhythm Technologies. MarketBeat recorded 20 mentions for National Vision and 5 mentions for iRhythm Technologies. iRhythm Technologies' average media sentiment score of 1.47 beat National Vision's score of 1.07 indicating that iRhythm Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
iRhythm Technologies	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
National Vision	9 Very Positive mention(s)	4 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

National Vision beats iRhythm Technologies on 8 of the 15 factors compared between the two stocks.

How does National Vision compare to Liquidia?

Liquidia (NASDAQ:LQDA) and National Vision (NASDAQ:EYE) are both medical equipment companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, profitability, earnings, media sentiment, risk, analyst recommendations, institutional ownership and dividends.

Liquidia currently has a consensus price target of $49.33, suggesting a potential downside of 16.81%. National Vision has a consensus price target of $29.31, suggesting a potential upside of 65.39%. Given National Vision's higher possible upside, analysts clearly believe National Vision is more favorable than Liquidia.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Liquidia	2 Sell rating(s)	0 Hold rating(s)	7 Buy rating(s)	3 Strong Buy rating(s)	2.92
National Vision	0 Sell rating(s)	6 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.54

Liquidia has a net margin of 7.74% compared to National Vision's net margin of 1.49%. Liquidia's return on equity of 46.82% beat National Vision's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Liquidia	7.74%	46.82%	7.06%
National Vision	1.49%	5.15%	2.22%

In the previous week, Liquidia had 30 more articles in the media than National Vision. MarketBeat recorded 50 mentions for Liquidia and 20 mentions for National Vision. National Vision's average media sentiment score of 1.07 beat Liquidia's score of 0.56 indicating that National Vision is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Liquidia	14 Very Positive mention(s)	6 Positive mention(s)	13 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive
National Vision	9 Very Positive mention(s)	4 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

64.5% of Liquidia shares are held by institutional investors. 25.6% of Liquidia shares are held by insiders. Comparatively, 2.4% of National Vision shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

National Vision has higher revenue and earnings than Liquidia. National Vision is trading at a lower price-to-earnings ratio than Liquidia, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Liquidia	$288.07M	18.31	-$68.92M	$0.14	423.57
National Vision	$1.99B	0.71	$29.60M	$0.37	47.89

Liquidia has a beta of 0.41, meaning that its stock price is 59% less volatile than the broader market. Comparatively, National Vision has a beta of 1.18, meaning that its stock price is 18% more volatile than the broader market.

Summary

Liquidia beats National Vision on 10 of the 16 factors compared between the two stocks.

Get National Vision News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EYE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

EYE vs. The Competition

Export

Metric	National Vision	CONS PD Industry	Staples Sector	NASDAQ Exchange
Market Cap	$1.42B	$30.14B	$16.11B	$12.46B
Dividend Yield	N/A	3.38%	3.49%	5.30%
P/E Ratio	47.89	78.40	23.21	25.59
Price / Sales	0.71	1.50	47.47	63.24
Price / Cash	11.70	30.87	16.36	55.34
Price / Book	1.62	11.44	5.27	6.70
Net Income	$29.60M	$1.33B	$671.44M	$333.77M
7 Day Performance	-22.38%	-2.01%	-1.29%	0.45%
1 Month Performance	-30.15%	-2.46%	-1.76%	4.06%
1 Year Performance	-4.88%	-17.35%	-11.79%	36.24%

National Vision Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
EYE National Vision	4.3387 of 5 stars	$17.72 +4.7%	$29.31 +65.4%	-10.3%	$1.42B	$1.99B	47.89	13,138	Trending News Earnings Report Analyst Forecast High Trading Volume
NVST Envista	3.4662 of 5 stars	$25.90 -1.6%	$28.25 +9.1%	+28.0%	$4.29B	$2.72B	92.20	12,000	Analyst Downgrade
BLCO Bausch + Lomb	4.2825 of 5 stars	$16.23 -0.5%	$18.08 +11.4%	+36.8%	$5.81B	$5.10B	N/A	13,000	News Coverage Positive News
STVN Stevanato Group	2.9974 of 5 stars	€18.10 +1.8%	N/A	-28.0%	€5.43B	€1.34B	30.89	6,010	Earnings Report
IRTC iRhythm Technologies	4.3822 of 5 stars	$118.25 -0.8%	$193.38 +63.5%	-18.0%	$3.92B	$787.85M	N/A	2,400	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:EYE) was last updated on 5/14/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

National Vision (EYE) Competitors

EYE vs. NVST, BLCO, STVN, IRTC, and LQDA

How does National Vision compare to Envista?

Summary

How does National Vision compare to Bausch + Lomb?

Summary

How does National Vision compare to Stevanato Group?

Summary

How does National Vision compare to iRhythm Technologies?

Summary

How does National Vision compare to Liquidia?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

EYE vs. The Competition

National Vision Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

National Vision (EYE) Competitors

EYE vs. NVST, BLCO, STVN, IRTC, and LQDA

How does National Vision compare to Envista?

Which has better valuation and earnings, EYE or NVST?

Is EYE or NVST more profitable?

Does the media refer more to EYE or NVST?

Which has more volatility and risk, EYE or NVST?

Do analysts recommend EYE or NVST?

Summary

How does National Vision compare to Bausch + Lomb?

Which has preferable valuation & earnings, EYE or BLCO?

Do insiders & institutionals hold more shares of EYE or BLCO?

Is EYE or BLCO more profitable?

Does the media prefer EYE or BLCO?

Which has more volatility and risk, EYE or BLCO?

Do analysts prefer EYE or BLCO?

Summary

How does National Vision compare to Stevanato Group?

Do analysts prefer EYE or STVN?

Which has preferable valuation & earnings, EYE or STVN?

Which has more risk & volatility, EYE or STVN?

Is EYE or STVN more profitable?

Does the media refer more to EYE or STVN?

Summary

How does National Vision compare to iRhythm Technologies?

Do analysts prefer IRTC or EYE?

Which has better valuation and earnings, IRTC or EYE?

Which has more volatility & risk, IRTC or EYE?

Is IRTC or EYE more profitable?

Does the media favor IRTC or EYE?

Summary

How does National Vision compare to Liquidia?

Do analysts prefer LQDA or EYE?

Is LQDA or EYE more profitable?

Does the media prefer LQDA or EYE?

Do institutionals & insiders hold more shares of LQDA or EYE?

Which has better valuation and earnings, LQDA or EYE?

Which has more risk and volatility, LQDA or EYE?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

EYE vs. The Competition

National Vision Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools